Skip to main content
Equibles

Sio Capital Management, LLC

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 1482416 NEW YORK, NY
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
New position
Shares Held
0
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record

Derivatives in SLS

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$18,165,132
PutShares
1,230,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Sio Capital Management, LLC holds $224,951,128 across 32 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 ALLO
Allogene Therapeutics, Inc.
 13,323,431 $27,712,736
2 TYRA
Tyra Biosciences, Inc.
 695,315 $22,208,361
3 IDYA
IDEAYA Biosciences, Inc.
 480,383 $17,903,874
4 ORKA
Oruka Therapeutics, Inc.
 177,118 $16,856,320
5 RAPP
Rapport Therapeutics, Inc.
 307,657 $12,820,067
6 CELC
Celcuity Inc.
 110,022 $11,510,501
7 REGN
Regeneron Pharmaceuticals, Inc.
 18,000 $11,223,720
8 VIR
Vir Biotechnology, Inc.
 1,075,274 $10,957,042

All Filings in SLS

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $18,165,132 1,230,700